Lenalidomide for fayetteville VAMC patient care
Active Awarded Last action
- Contract number
- 36C24626N0422
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $3,496,483
Award facts
- Contract value 100% obligated
- $3,496,483.48 Current and potential, with all options
- Completion date 76% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Boca Raton, FL 33432, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 6, awarded a delivery order valued at $3.50 million to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide to support patient care at the Fayetteville VAMC. This firm-fixed-price delivery order, issued on January 15, 2026, with an ultimate completion date of January 14, 2027, represents a continuation of Exelan's role as a critical pharmaceutical supplier to the VA healthcare system. The contract carries no set-aside designation, allowing Exelan to compete on an unrestricted basis. Performance will be executed at Exelan's Boca Raton, Florida facility, which serves as the company's primary manufacturing and distribution hub for federal pharmaceutical procurement.
This delivery order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), leveraging the larger framework agreement established between the VA and Exelan. Lenalidomide is a critical therapeutic agent used in the treatment of oncologic and hematologic malignancies within the VA system, and Exelan has demonstrated substantial experience fulfilling similar requirements across multiple Veterans Integrated Service Networks. As a foreign-owned pharmaceutical company with specialized expertise in generic and branded drug repackaging and distribution, Exelan operates as a prime contractor with no identified major subcontractors and maintains an extensive portfolio of indefinite delivery contracts supporting federal healthcare agencies including the Department of Defense, Bureau of Prisons, and Indian Health Service.
Quick answers
Who was awarded contract 36C24626N0422?
36C24626N0422 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on January 15, 2026.
How much is contract 36C24626N0422 worth?
The government has obligated $3,496,483 on 36C24626N0422.
Is contract 36C24626N0422 an order under another contract?
Yes. 36C24626N0422 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24626N0422 competed?
The extent of competition for 36C24626N0422 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award